Press Releases

Date Title
4/29/22 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4/27/22 Sarepta Therapeutics to Announce First Quarter 2022 Financial Results and Recent Corporate Developments on May 4, 2022
3/31/22 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/8/22 Sarepta Therapeutics Announces Fifth Year of Route 79, The Duchenne Scholarship Program
3/8/22 Sarepta Therapeutics anuncia quinto año de Route 79, El Programa de Becas Duchenne
3/2/22 Sarepta Therapeutics to Present at Upcoming Investor Conferences
3/1/22 Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2021 Financial Results and Recent Corporate Developments
2/28/22 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/22/22 Sarepta Therapeutics Announces the Launch of SareptaCircle to Highlight the Experiences of Individuals and Families Living with Rare Disease
2/22/22 Sarepta Therapeutics anuncia el lanzamiento de SareptaCircle para destacar las experiencias de personas y familias que viven con enfermedades raras
Displaying 91 - 100 of 812